IAS 2023, the 12th IAS Conference on HIV Science, Brisbane, Australia, and virtually, 23-26 July 2023

IAS 2023，第 12 届 IAS HIV 科学会议，澳大利亚布里斯班，虚拟会议，2023 年 7 月 23-26 日

• 批准号: 10696505
• 负责人: Christopher C. Beyrer
• 金额: $ 75万
• 依托单位: IAS
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-05-01 至 2024-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10696505
• 关键词: 2019-nCoV; AIDS prevention; Acceleration; Acquired Immunodeficiency Syndrome; Address; Affect; Antibody Response; Antiviral Agents; Area; Asia; Attention; Australia; Basic Science; Behavioral; Behavioral Sciences; COVID-19; COVID-19 impact; COVID-19 pandemic; COVID-19 pandemic effects; Caring; Clinic; Clinical; Clinical Sciences; Communities; Competence; Complex; Consensus; Country; Couples; Development; Discrimination; Disease remission; Economics; Emergency response; Ensure; Epidemic; Epidemiology; Formulation; Fostering; Geography; Goals; Guidelines; HIV; HIV Infections; HIV vaccine; Health; Health Personnel; Health system; Human; Human immunodeficiency virus test; Hybrids; Immunology; Improve Access; Incidence; Individual; Infection; Infrastructure; International; International AIDS; Intervention; Knowledge; Leadership; Life; Messenger RNA; Methods; Minority; Monkeypox; Outcome; Outcomes Research; Participant; Pathogenesis; Personal Satisfaction; Persons; Pharmaceutical Preparations; Policies; Policy Maker; Politics; Population; Populations at Risk; Prevention; Prevention Research; Prevention approach; Prevention program; Private Sector; Public Health; RNA vaccine; Research; Research Personnel; Resource-limited setting; Rights; Scholarship; Science; Scientist; Social Sciences; Stigmatization; Structure; System; Technology; Testing; Translating; Treatment outcome; Vaccines; Viral; Viral hepatitis; Work; base; civil society; co-infection; comorbidity; cost effective; design; exhibitions; experience; forging; gender diversity; gene therapy; implementation barriers; implementation research; implementation science; improved; indigenous community; innovation; insight; interdisciplinary collaboration; low and middle-income countries; marginalization; marginalized population; meetings; member; men who have sex with men; multidisciplinary; neutralizing antibody; novel; pandemic disease; pandemic preparedness; patient oriented; person centered; posters; precision medicine; prevention practice; programs; public health emergency; response; scale up; sex; social; social health determinants; social stigma; success; symposium; synergism; transmission process; uptake; vaccinology; viral pandemic; virology; virtual

Project Summary IN 2021 UNAIDS estimated the HIV incidence to have been 1.5 million new infections, while the 2020 target was set to be under 500,000 global infections for that year. At this rate, the HIV response is sharply off target to achieve the goal of an end to the pandemic as the global public health threat by 2030. The COVID-19 pandemic has severely affected the HIV response as it has caused consequential disruption in the HIV response, HIV testing and prevention. Furthermore, with WHO’s declaration of Monkeypox as a public health emergency of international concern, and this new emergence currently occurring overwhelmingly among men who have sex with men, a community with a very high burden for HIV, there are currently three concurrent pandemics underway challenging human health and wellbeing, health systems, and fragile public health infrastructures worldwide. IAS 2023 must address HIV science in the context of a wider pandemic preparedness and with a view toward the impacts of COVID-19 and Monkeypox on persons living with HIV, and on health systems and providers. Vaccine science will be prominent, as well as antiviral agents and their interactions for all three of these viral pandemics. Accelerate basic science and clinical science innovation in the development and application of person-centered precision medicine for HIV treatment, reducing HIV transmission, vaccines, pathogenesis, co-infections, and the search for a cure will feature prominently at IAS 2023. Specific aims of IAS 2023 will be to: 1. Advance inter-disciplinary collaboration in implementation research to reduce HIV transmission and improve treatment outcomes across all life-stages with a special focus on translating research outcomes into policy and practice through simplified practical guidelines for low- and middle-income countries and key populations. 2. Strengthen HIV prevention research to improve cost-effective biomedical, behavioral and structural interventions with a special focus on understanding implementation challenges, overcoming system barriers and replicating successes in HIV prevention practice and programs. 3. Address HIV vulnerability, determinants of HIV burdens and poor clinical outcomes among key and marginalized populations, including interventions to reduce stigma and discrimination and improve access and uptake of ART for prevention and treatment with a special focus on First Nations and Indigenous communities and on person-centered approaches. 4. Re-engage and reenergize community, clinical, social and political efforts to address unmet HIV needs and strengthen HIV policy in the Asia-Pacific region in the COVID-19 era, paying special attention to the needs of marginalized First Nations and Indigenous communities. The scientific program will be structured along five scientific tracks: basic science; clinical science; epidemiology & prevention science; social and behavioural sciences; implementation science, economics, systems and synergies. Topics to be addressed in each thematic area are described below. The scientific program is developed by a multi-disciplinary international Organizing Committee whose members are selected on the bases of scientific, policy and implementation expertise, meaningful engagement and representation of key and affected populations, of civil society and / or young people and geographic and gender diversity as key competencies and attributes ensuring diversity at all levels. Cross-cutting aspects will be highlighted in plenary talks that also connect the science with community and leadership perspectives. Additionally, bridging sessions are designed to cut across the different thematic areas to provide opportunities for multi-disciplinary, multi- perspective dialogues, often using interactive formats. Building on the success of the 24th International AIDS Conference - AIDS 2022 in hybrid format, IAS 2023 will be held in-person and virtually, providing many opportunities for discussions, debates and interconnection between the in-person and virtual speakers and audiences. Expected attendance is 6,000 HIV scientists, clinicians, policy makers, and program implementers as well as civil society, community and private sector representatives (4,500 in person and 1,500 online). IAS 2023 will provide scholarships to ensure the full participation of researchers, community activists and civil society representatives, especially those from resource-limited settings and underrepresented communities. Guided by best practices, the hybrid format will maximize inclusive conference experiences for all stakeholders at all levels.

项目摘要 联合国艾滋病规划署估计，2021年艾滋病毒感染率为150万新感染，而2020年的目标是 那一年的全球感染人数将低于50万。按照这个速度，艾滋病毒应对措施严重偏离目标， 实现到2030年消除这一大流行病对全球公共卫生的威胁的目标。 COVID-19大流行严重影响了艾滋病毒应对工作，因为它导致了 艾滋病毒应对、艾滋病毒检测和预防。此外，随着世卫组织宣布猴痘为公共疾病， 国际关注的卫生紧急情况，而这一新出现的情况目前绝大多数发生在 男男性行为者，一个艾滋病毒负担非常高的社区，目前有三个并发 正在发生的流行病对人类健康和福祉、卫生系统以及脆弱的公共卫生构成挑战 全球基础设施。IAS 2023必须在更广泛的大流行准备背景下解决艾滋病毒科学问题 并着眼于COVID-19和猴痘对艾滋病毒感染者和健康的影响 系统和提供商。疫苗科学将是突出的，以及抗病毒剂和它们的相互作用， 这三种病毒性流行病在发展中加快基础科学和临床科学创新 以及应用以人为本的精准医学治疗艾滋病毒，减少艾滋病毒传播，疫苗， 发病机制、合并感染和寻找治愈方法将在IAS 2023上占据突出地位。 IAS 2023的具体目标是： 1.在实施研究方面推进跨学科合作，以减少艾滋病毒传播， 所有生命阶段的治疗结果，特别注重将研究成果转化为政策 低收入和中等收入国家简化实用指南， 人口。 2.加强艾滋病毒预防研究，以改善具有成本效益的生物医学、行为和结构 干预措施，特别侧重于了解执行挑战，克服系统障碍 并在艾滋病毒预防实践和方案中复制成功经验。 3.解决艾滋病毒脆弱性、艾滋病毒负担的决定因素和关键和 边缘化群体，包括采取干预措施，减少污名化和歧视， 采用抗逆转录病毒疗法进行预防和治疗，特别关注原住民和土著人 社区和以人为本的方法。 4. * 重新参与和振兴社区、临床、社会和政治努力，以解决未得到满足的艾滋病毒需求， 加强亚太地区在COVID-19时代的艾滋病毒政策，特别关注 被边缘化的第一民族和土著社区。 科学计划将沿着沿着五个科学轨道进行：基础科学;临床科学;流行病学 预防科学;社会和行为科学;实施科学、经济学、系统和 协同作用。下文介绍了每个专题领域要处理的议题。科学计划是 由一个多学科的国际组织委员会开发，其成员是根据以下基础选择的： 科学、政策和执行方面的专门知识， 受影响人口、民间社会和（或）青年以及地域和性别多样性是关键 确保各级多样性的能力和属性。将在全体会议上强调贯穿各领域的问题 这些讲座还将科学与社区和领导观点联系起来。此外，桥接会议 旨在跨越不同的主题领域，为多学科，多学科， 观点对话，经常使用互动形式。 在第24届国际艾滋病大会-艾滋病2022年混合形式成功的基础上，IAS 2023将 面对面和虚拟地举行，提供许多讨论、辩论和相互联系的机会 在现场和虚拟演讲者和观众之间。预计将有6,000名艾滋病毒科学家出席， 临床医生、政策制定者和项目实施者以及民间社会、社区和私营部门 代表（4 500人亲自参加，1 500人在线参加）。IAS 2023将提供奖学金，以确保充分的 研究人员、社区活动家和民间社会代表，特别是来自 资源有限和代表性不足的社区。在最佳做法的指导下，混合格式将 最大限度地为各级所有利益攸关方提供包容性的会议体验。